Ispire Technology Inc. ISPR Stock options excluded as their inclusion would be anti-dilutive (in shares)

Stock options excluded as their inclusion would be anti-dilutive (in shares) at other companies

Achieve Life SciencesACHV

26.6M+17.2%

Revenue$18.7M-28.7%

Gross profit$2.0M-58.3%

Operating income-$9.5M+10.4%

Net income-$9.5M+12.3%

EPS (diluted)-$0.17+10.5%

Cash & equivalents$18.0M-23.6%

Total debt$3.8M-40.8%

Total equity-$16.2M-210%

Total assets$75.9M-34.4%

Operating cash flow-$4.0M—

CapEx$247.3K—

Free cash flow-$4.0M—

Market cap$64.29M-41.7%

Enterprise value$50.07M-45.1%

P/S0.7×-0.1×

Gross margin14.6%-6.6pp

Operating margin-37.7%-871pp

Net margin-38.2%+1,627pp

FCF margin-27.4%-31.5pp

Return on equity-223.8%-299pp

Debt / equity9.8×+9.7×

Current ratio1×0.0×

Reported directly by Ispire Technology Inc. in its filing.

Tagged under the XBRL concept us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.

The official record: Ispire Technology Inc.’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Ispire Technology Inc.'s stock options excluded as their inclusion would be anti-dilutive (in shares)?: Ispire Technology Inc. (ISPR) reported stock options excluded as their inclusion would be anti-dilutive (in shares) of 2.5M in Q3 2025.
What does stock options excluded as their inclusion would be anti-dilutive (in shares) mean?: The number of stock options, restricted stock units, or other equity instruments excluded from the diluted earnings per share calculation because their inclusion would increase earnings per share or decrease the loss per share. This metric helps investors understand the potential future dilution that is currently excluded from standard performance reporting.